HRTX
USDHeron Therapeutics Inc. Common Stock
Preço em tempo real
Gráfico de preços
Métricas-chave
Métricas de mercado
Abertura
$1.170
Máximo
$1.190
Mínimo
$1.070
Volume
1.54M
Fundamentos da empresa
Capitalização de mercado
202.6M
Setor
Biotecnologia
País
United States
Estatísticas de negociação
Volume médio
1.92M
Bolsa de valores
NCM
Moeda
USD
Faixa de 52 semanas
Notícias relacionadas
Heron Therapeutics Announces Q3 2025 Financial Results and Highlights Commercial Progress
Generated Q3 2025 Net Revenue of $38.2 million and year-to-date revenue of $114.3 million; reaffirmed 2025 Net Revenue Guidance of $153 million - $163 million and adjusted EBITDA of $9.0 - $13.0 millionZYNRELEF® Net
Heron Therapeutics Announces Appointment of Thomas Cusack to Board of Directors
CARY, N.C., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (NASDAQ:HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced the appointment of Thomas Cusack to its Board
Heron Therapeutics to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025
CARY, N.C., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (NASDAQ:HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced that the Company will host a conference call
Ações relacionadas
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.